Search results for abx831328

Durvalumab, Abbexa, abx831328

Durvalumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD274, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Durvalumab (MEDI 4736) is an humanized anti-PD-L1 monoclonal antibody, it completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0. 1 and 0. 04 nM, respectively. （适用于人源及非人源化小鼠）